By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Oncology development activities13.12M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
China5.2M65.82%
Japan2.7M34.18%